SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-19-058070
Filing Date
2019-10-31
Accepted
2019-10-31 07:37:04
Documents
15
Period of Report
2019-10-31
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm1921268-1_8k.htm   iXBRL 8-K 28624
2 EXHIBIT 99.1 tm1921268d1_ex99-1.htm EX-99.1 445921
7 GRAPHIC tm1921268d1_ex99-1img001.jpg GRAPHIC 9488
  Complete submission text file 0001104659-19-058070.txt   738880

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA celg-20191031.xsd EX-101.SCH 3686
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE celg-20191031_def.xml EX-101.DEF 28203
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE celg-20191031_lab.xml EX-101.LAB 37008
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE celg-20191031_pre.xml EX-101.PRE 26828
8 EXTRACTED XBRL INSTANCE DOCUMENT tm1921268-1_8k_htm.xml XML 5122
Mailing Address 86 MORRIS AVENUE SUMMIT NJ 07901
Business Address 86 MORRIS AVENUE SUMMIT NJ 07901 (908)673-9000
CELGENE CORP /DE/ (Filer) CIK: 0000816284 (see all company filings)

IRS No.: 222711928 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34912 | Film No.: 191182113
SIC: 2834 Pharmaceutical Preparations